Oliver Freudenreich, MD
Psychosis Clinical and Research Program, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts
- 27Articles
- 126.4KReads1
- 2000–2025Active
- 73Collaborators
- 343Citations2
About
Oliver Freudenreich, MD, is affiliated with the Psychosis Clinical and Research Program at Massachusetts General Hospital/Harvard Medical School. With publications spanning from 2000 to 2025, Freudenreich has contributed extensively to research on schizophrenia, schizoaffective disorders, metabolic complications related to psychiatric treatment, neurology, addiction, bipolar and mood disorders, and patient care during the COVID-19 pandemic. His work includes studies on antipsychotic treatment strategies, adherence monitoring, and the clinical management of treatment-resistant cases. Frequent collaborators include Donald C. Goff, A. Eden Evins, and David C. Henderson.
Publications
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
